0000899243-20-024397.txt : 20200904
0000899243-20-024397.hdr.sgml : 20200904
20200904190327
ACCESSION NUMBER: 0000899243-20-024397
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200512
FILED AS OF DATE: 20200904
DATE AS OF CHANGE: 20200904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Invest Corp
CENTRAL INDEX KEY: 0001534428
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 201162717
BUSINESS ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 0119611363362
MAIL ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Partners Foundation, L.P.
CENTRAL INDEX KEY: 0001783583
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 201162718
BUSINESS ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 961 1 363 362
MAIL ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Umari Abude
CENTRAL INDEX KEY: 0001783582
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 201162719
MAIL ADDRESS:
STREET 1: STARCO CTR, BLOC B, 3RD FLOOR
STREET 2: OMAR DAUOK STREET
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZEIN YOUSSEF EL
CENTRAL INDEX KEY: 0001193366
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 201162720
MAIL ADDRESS:
STREET 1: HYBRIDON INC
STREET 2: 345 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 4843481600
MAIL ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-12
0
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001534428
Pillar Invest Corp
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001783583
Pillar Partners Foundation, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001783582
Umari Abude
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
0001193366
ZEIN YOUSSEF EL
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
0
0
1
0
Common Warrants
2020-05-12
4
P
0
3039514
A
Common Stock
3039514
3039514
I
By Pillar Partners Foundation, L.P. See Footnote
On April 7, 2020, upon the consummation of a private placement of the Issuer, Pillar Partners Foundation, L.P. ("Pillar Foundation"), acquired, in the Private Placement, 3,039,514 shares of common stock (the "Pillar Foundation Shares") as well as warrants to purchase 3,039,514 shares of common stock of the Issuer (the "Pillar Foundation Warrants"). Each Pillar Foundation Share and the associated Pillar Foundation Warrant had a combined purchase price of $1.645, which combined purchase price included $0.125 for each share of common stock underlying each Pillar Foundation Warrant. The exercise price of each Pillar Foundation Warrant is $2.28 per share, subject to adjustment pursuant to the terms of the Pillar Foundation Warrants and the Pillar Foundation Warrants expire 3 years from their issuance date.
The Pillar Foundation Warrants became exercisable on May 12, 2020 following receipt of shareholder approval for the sufficient increase in the Issuer's authorized shares of common stock to cover the exercise of the Pillar Foundation Warrants. The Pillar Foundation Warrants are exercisable, to the extent that after giving effect to such exercise the holders thereof and their affiliates would beneficially own, for purposes of Rule 13d-3 under the Securities Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer.
Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals I, L.P., Pillar Pharmaceuticals II, L.P., Pillar Pharmaceuticals III, L.P., Pillar Pharmaceuticals IV, L.P., Pillar Pharmaceuticals V, L.P., Pillar Pharmaceuticals 6, L.P. and Pillar Foundation (collectively, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
2020-09-04
Pillar Partners Foundation, L.P., /s/ Youssef El Zein, Authorized Person
2020-09-04
/s/ Abude Umari
2020-09-04
/s/ Youssef El Zein
2020-09-04